Amphipathic DNA polymers exhibit antiviral activity against systemic murine Cytomegalovirus infection.
about
Designing anti-influenza aptamers: novel quantitative structure activity relationship approach gives insights into aptamer-virus interactionEmerging antivirals for the treatment of hepatitis B.Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytesEmerging drugs for varicella-zoster virus infections.Squalamine as a broad-spectrum systemic antiviral agent with therapeutic potential.Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection.Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B InfectionAmphipathic properties of HIV-1 gp41 fusion inhibitors.Nucleic acid polymers prevent the establishment of duck hepatitis B virus infection in vivo.Nucleic acid-based polymers effective against hepatitis B Virus infection in patients don't harbor immunostimulatory properties in primary isolated liver cells.Oligonucleotides designed to inhibit TLR9 block Herpes simplex virus type 1 infection at multiple steps.Nucleic acid polymers inhibit duck hepatitis B virus infection in vitro.Nucleic acid polymers are active against Hepatitis Delta Virus infection in vitro.Activity of nucleic acid polymers in rodent models of HBV infection.
P2860
Q33638356-09AB46F8-17CE-41A4-ACD3-AC2F4C5F9216Q33801328-D049B814-F94C-494E-A7CE-3990CE25C618Q33821878-CEDA88D7-EE9C-4533-A027-CCADD7FC9AC1Q34027426-DD9057BA-D837-4F15-88E2-CC55D6F71F6BQ34217620-D9629CA7-4131-4CD0-894F-9F3719E1E49CQ35839139-BEF7898E-8B2D-4430-9BE4-22FD1CD1BD09Q36039553-4E21DF41-A7A9-402A-BD25-55934697EED0Q37951610-5226F5F4-DAD9-4045-AF13-4A1390C350DAQ39368000-5B429559-FDAE-43EE-BA2A-A33BCD1CEC66Q40302798-4D45D370-1CB6-44ED-B014-49B00BD5B088Q42207445-B6F6D60D-33CF-48D2-90C5-AC35751CBFAEQ42277109-DDF5217D-7A38-4C81-8B12-B4FCB0FFD6A4Q45323707-8F02129C-9B0F-4265-A03A-2322317521F4Q46263692-E7D3ED29-CF9B-4F17-8120-62A6F7B9C53B
P2860
Amphipathic DNA polymers exhibit antiviral activity against systemic murine Cytomegalovirus infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Amphipathic DNA polymers exhib ...... ine Cytomegalovirus infection.
@en
Amphipathic DNA polymers exhib ...... ine Cytomegalovirus infection.
@nl
type
label
Amphipathic DNA polymers exhib ...... ine Cytomegalovirus infection.
@en
Amphipathic DNA polymers exhib ...... ine Cytomegalovirus infection.
@nl
prefLabel
Amphipathic DNA polymers exhib ...... ine Cytomegalovirus infection.
@en
Amphipathic DNA polymers exhib ...... ine Cytomegalovirus infection.
@nl
P2093
P2860
P356
P1433
P1476
Amphipathic DNA polymers exhib ...... ine Cytomegalovirus infection.
@en
P2093
Andrea P Sewell
Andrew Vaillant
David I Bernstein
Fernando J Bravo
James Cummins
Jean-Marc Juteau
Louis Flamand
Rhonda D Cardin
P2860
P356
10.1186/1743-422X-6-214
P577
2009-12-02T00:00:00Z